Charles W. Drescher

Gynecologic Oncology Group — United States

Medicine · Health Sciences

50h-index15.4kcitations281works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(128), Endometrial and Cervical Cancer Treatments(30), CAR-T cell therapy research(28), BRCA gene mutations in cancer(27), Cancer Research and Treatments(27)

Publications281 total

Financial Distress Screening and Financial Navigation Among Adolescents and Young Adults Within the National Cancer Institute Community Oncology Research Program: Results of the 2022 Landscape Survey
JCO Oncology Practice·2025
Abstract IA009: Immune suppression in the fallopian tube: Insights from the pre-cancer atlas
Cancer Research·2025
A phase II trial of stenoparib (2×-121): A novel dual tankyrase and poly (ADP-ribose) polymerase inhibitor in advanced, recurrent ovarian cancer
Gynecologic Oncology·2025
Treatment, outcomes, and resource utilization among patients with metastatic breast and advanced epithelial ovarian cancer, by BRCA1/2 and HRD status
The Oncologist·2025· 1 citedOpen Access
Fertility Preservation Services for Adolescents and Young Adults: 2022 National Cancer Institute Community Oncology Research Program Landscape Assessment
JCO Oncology Practice·2025· 1 citedOpen Access
Supplementary Methods from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S7 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S10 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S5 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S8 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Figures 1 to 29 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S3 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S4 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S6 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S1 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S11 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Data from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Video from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S2 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
Supplementary Table S9 from Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
2025Open Access
page 1 of 15Next →

Frequent Co-authors

Nicole Urban(29), Martin McIntosh(11), Kathy O'Briant(10), Jason D. Thorpe(8), Nathalie Scholler(8), Muneesh Tewari(7), Lindsay Bergan(7), Andrew K. Godwin(6), Garnet L. Anderson(6), Pamela J. Paley(6), Rachael K. Parkin(5), Beatrice S. Knudsen(5), M. Robyn Andersen(5), Chirag Shah(5), William A. Peters(5), André Lieber(4), Stacia K. Wyman(3), Robert Gentleman(3), Ingegerd Hellström(3), Michèl Schummer(3)